Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMID 11684012)

Published in Mol Cell on October 01, 2001

Authors

W Lu1, D Gong, D Bar-Sagi, P A Cole

Author Affiliations

1: Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Articles citing this

Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J (2003) 10.77

CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest (2008) 3.29

Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev (2008) 2.40

SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev (2009) 1.78

Protein tyrosine phosphatases in the JAK/STAT pathway. Front Biosci (2008) 1.63

The chemical biology of protein phosphorylation. Annu Rev Biochem (2009) 1.59

Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia. J Cell Biol (2006) 1.48

Biological applications of protein splicing. Cell (2010) 1.40

Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J Biol Chem (2010) 1.36

The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacol Ther (2006) 1.27

Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells. Cell Signal (2011) 1.21

SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans. J Clin Invest (2011) 1.16

Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation. J Am Chem Soc (2010) 1.15

M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification. Blood (2009) 1.11

SHP2 mediates the localized activation of Fyn downstream of the α6β4 integrin to promote carcinoma invasion. Mol Cell Biol (2010) 1.04

Structure-based kinetic models of modular signaling protein function: focus on Shp2. Biophys J (2007) 1.03

The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells. Exp Cell Res (2009) 1.02

Modular evolution of phosphorylation-based signalling systems. Philos Trans R Soc Lond B Biol Sci (2012) 1.02

Phosphorylation-mediated PTEN conformational closure and deactivation revealed with protein semisynthesis. Elife (2013) 1.02

SHP-2 is a novel target of Abl kinases during cell proliferation. J Cell Sci (2008) 1.01

Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration. J Immunol (2013) 1.01

Impaired Rho GTPase activation abrogates cell polarization and migration in macrophages with defective lipolysis. Cell Mol Life Sci (2011) 1.00

Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling. Sci Signal (2011) 0.99

Streamlined expressed protein ligation using split inteins. J Am Chem Soc (2012) 0.99

S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation. PLoS One (2008) 0.97

The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo. Leukemia (2012) 0.97

The p75 receptor mediates axon growth inhibition through an association with PIR-B. Cell Death Dis (2011) 0.96

S-nitrosylated SHP-2 contributes to NMDA receptor-mediated excitotoxicity in acute ischemic stroke. Proc Natl Acad Sci U S A (2013) 0.95

The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation. Mol Biol Cell (2012) 0.94

Cannabinoid 1 receptor and interleukin-6 receptor together induce integration of protein kinase and transcription factor signaling to trigger neurite outgrowth. J Biol Chem (2009) 0.93

Grb2 controls phosphorylation of FGFR2 by inhibiting receptor kinase and Shp2 phosphatase activity. J Cell Biol (2013) 0.92

A THEMIS:SHP1 complex promotes T-cell survival. EMBO J (2014) 0.92

Klotho regulates retinal pigment epithelial functions and protects against oxidative stress. J Neurosci (2013) 0.91

SHP2 tyrosine phosphatase stimulates CEBPA gene expression to mediate cytokine-dependent granulopoiesis. Blood (2011) 0.91

Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2. J Cell Sci (2009) 0.91

Identification of targets of c-Src tyrosine kinase by chemical complementation and phosphoproteomics. Mol Cell Proteomics (2012) 0.90

Paired immunoglobulin-like receptor B regulates platelet activation. Blood (2014) 0.89

Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling. Cold Spring Harb Perspect Biol (2013) 0.89

Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2. Biochem J (2004) 0.89

Functions of Shp2 in cancer. J Cell Mol Med (2015) 0.88

Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling. Immunol Rev (2015) 0.87

Protein phosphorylation by semisynthesis: from paper to practice. Methods Enzymol (2009) 0.87

Shp2 acts downstream of SDF-1alpha/CXCR4 in guiding granule cell migration during cerebellar development. Dev Biol (2009) 0.86

Novel functions of the phosphatase SHP2 in the DNA replication and damage checkpoints. PLoS One (2012) 0.85

Molecular basis of gain-of-function LEOPARD syndrome-associated SHP2 mutations. Biochemistry (2014) 0.84

F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance. Leukemia (2015) 0.84

Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasion. PLoS One (2013) 0.83

Signaling mechanisms regulating myelination in the central nervous system. Neurosci Bull (2013) 0.83

Phosphoproteomic Analyses of Interleukin 2 Signaling Reveal Integrated JAK Kinase-Dependent and -Independent Networks in CD8(+) T Cells. Immunity (2016) 0.82

Shp2 Associates with and Enhances Nephrin Tyrosine Phosphorylation and Is Necessary for Foot Process Spreading in Mouse Models of Podocyte Injury. Mol Cell Biol (2015) 0.81

Antagonism between binding site affinity and conformational dynamics tunes alternative cis-interactions within Shp2. Nat Commun (2013) 0.80

Dysregulation of janus kinases and signal transducers and activators of transcription in cancer. Am J Cancer Res (2011) 0.80

Curcumin inhibits interferon-γ signaling in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol (2011) 0.80

SH2 domain-containing protein tyrosine phosphatase 2 and focal adhesion kinase protein interactions regulate pulmonary endothelium barrier function. Am J Respir Cell Mol Biol (2015) 0.78

Loss of tyrosine phosphatase-dependent inhibition promotes activation of tyrosine kinase c-Src in detached pancreatic cells. Mol Carcinog (2010) 0.78

Proinflammatory stem cell signaling in cardiac ischemia. Antioxid Redox Signal (2009) 0.76

Structural basis of how stress-induced MDMX phosphorylation activates p53. Oncogene (2015) 0.75

Chemical Methods for Encoding and Decoding of Posttranslational Modifications. Cell Chem Biol (2016) 0.75

Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation. Cell Death Dis (2017) 0.75

Role of SHP2 protein tyrosine phosphatase in SERT inhibition by enteropathogenic E. coli (EPEC). Am J Physiol Gastrointest Liver Physiol (2017) 0.75

Articles by these authors

(truncated to the top 100)

Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science (2000) 8.56

The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell (1992) 8.20

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev (1993) 7.41

Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature (1993) 6.38

Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol (1999) 5.78

Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science (1993) 5.02

Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science (1986) 4.99

Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature (1993) 4.54

The structural basis of the activation of Ras by Sos. Nature (1998) 4.50

A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell (1997) 4.43

Expressed protein ligation: a general method for protein engineering. Proc Natl Acad Sci U S A (1998) 4.01

Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell (1985) 3.73

RAC regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase. Science (1996) 3.30

Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol (1997) 3.22

Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science (1996) 3.18

Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science (1998) 3.17

HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol Cell (2000) 2.68

Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science (1995) 2.42

Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol Cell (2000) 2.25

G-protein beta gamma-subunits activate the cardiac muscarinic K+-channel via phospholipase A2. Nature (1989) 2.14

Mechanism-based design of a protein kinase inhibitor. Nat Struct Biol (2001) 2.13

An SH3 binding region in the epithelial Na+ channel (alpha rENaC) mediates its localization at the apical membrane. EMBO J (1994) 2.10

Identification of a novel Rac1-interacting protein involved in membrane ruffling. EMBO J (1996) 2.00

Tethered blockers as molecular 'tape measures' for a voltage-gated K+ channel. Nat Struct Biol (2000) 1.89

Crystal structure of the Dbl and pleckstrin homology domains from the human Son of sevenless protein. Cell (1998) 1.77

Transcriptional coactivator protein p300. Kinetic characterization of its histone acetyltransferase activity. J Biol Chem (2001) 1.77

Differential activation of the Rac pathway by Ha-Ras and K-Ras. J Biol Chem (2001) 1.72

Structure-based mutagenesis reveals distinct functions for Ras switch 1 and switch 2 in Sos-catalyzed guanine nucleotide exchange. J Biol Chem (2001) 1.71

The Ras superfamily of GTPases. FASEB J (1996) 1.70

Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg (1997) 1.66

Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2. Mol Cell Biol (1996) 1.63

Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ (2004) 1.54

The role of the PH domain in the signal-dependent membrane targeting of Sos. EMBO J (1997) 1.54

Enhancing substance abuse treatment with case management. Its impact on employment. J Subst Abuse Treat (1997) 1.54

Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg (1997) 1.53

Naturally occurring variability in anesthetic potency among inbred mouse strains. Anesth Analg (2000) 1.51

Kinase suppressor of Ras inhibits the activation of extracellular ligand-regulated (ERK) mitogen-activated protein (MAP) kinase by growth factors, activated Ras, and Ras effectors. J Biol Chem (1998) 1.48

Rac1 mediates STAT3 activation by autocrine IL-6. Proc Natl Acad Sci U S A (2001) 1.46

Regulation of Sos activity by intramolecular interactions. Mol Cell Biol (1998) 1.46

Chromatin-dependent cooperativity between constitutive and inducible activation domains in CREB. Mol Cell Biol (2001) 1.46

Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1. Science (1994) 1.40

Ras effectors and their role in mitogenesis and oncogenesis. J Mol Med (Berl) (1997) 1.40

Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism. Biochemistry (1998) 1.39

p300/CBP-associated factor histone acetyltransferase processing of a peptide substrate. Kinetic analysis of the catalytic mechanism. J Biol Chem (2000) 1.38

A Rac1 effector site controlling mitogenesis through superoxide production. J Biol Chem (1998) 1.35

Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J Clin Invest (1992) 1.28

Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics) Anesth Analg (1998) 1.28

Blockade of AMPA receptors and volatile anesthetics: reduced anesthetic requirements in GluR2 null mutant mice for loss of the righting reflex and antinociception but not minimum alveolar concentration. Anesthesiology (2001) 1.27

Suppression of Ras-induced apoptosis by the Rac GTPase. Mol Cell Biol (1999) 1.26

Kinetic analysis of the catalytic mechanism of serotonin N-acetyltransferase (EC 2.3.1.87). J Biol Chem (1998) 1.20

Effect of tunicamycin, an inhibitor of protein glycosylation, on the biological properties of acetylcholine receptor in cultured muscle cells. J Biol Chem (1983) 1.18

The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A, in volunteers. Anesth Analg (1998) 1.14

Domain interactions in protein tyrosine kinase Csk. Biochemistry (1999) 1.13

Co-capping of ras proteins with surface immunoglobulins in B lymphocytes. Nature (1990) 1.12

Mouse strain modestly influences minimum alveolar anesthetic concentration and convulsivity of inhaled compounds. Anesth Analg (1999) 1.12

Divalent ion effects and insights into the catalytic mechanism of protein tyrosine kinase Csk. Biochemistry (1997) 1.12

Monitoring for compartmental syndrome using near-infrared spectroscopy: a noninvasive, continuous, transcutaneous monitoring technique. J Trauma (1999) 1.11

Chemical rescue of a mutant protein-tyrosine kinase. J Biol Chem (2000) 1.11

The solution structure of the pleckstrin homology domain of human SOS1. A possible structural role for the sequential association of diffuse B cell lymphoma and pleckstrin homology domains. J Biol Chem (1997) 1.10

Differential interactions of human Sos1 and Sos2 with Grb2. J Biol Chem (1995) 1.10

Activation of Ras and other signaling pathways by receptor tyrosine kinases. Cold Spring Harb Symp Quant Biol (1994) 1.09

Distal femoral fracture fixation utilizing the Less Invasive Stabilization System (L.I.S.S.): the technique and early results. Injury (2001) 1.09

Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation. Int J Cancer (2001) 1.09

Cell phenotype specific kinetics of expression of intratracheally injected manganese superoxide dismutase-plasmid/liposomes (MnSOD-PL) during lung radioprotective gene therapy. Gene Ther (2003) 1.08

Feasibility of obtaining sexual risk and STD history in the context of a drinking drivers' program. Public Health Rep (1998) 1.08

Fixation of distal femoral fractures above total knee arthroplasty utilizing the Less Invasive Stabilization System (L.I.S.S.). Injury (2001) 1.07

Molecular determinants for Csk-catalyzed tyrosine phosphorylation of the Src tail. Biochemistry (2001) 1.06

A study of hypertension in the inner city. A student hypertension survey. Am Heart J (1973) 1.02

Effects of menstrual phase on nicotine, alcohol, and caffeine intake in smokers. J Subst Abuse (1994) 1.02

Discovery of entry inhibitors for HIV-1 via a new de novo protein design framework. Biophys J (2010) 1.00

Triplication of the gallbladder: review of literature and report of a case. Am Surg (1979) 0.97

Degranulation of individual mast cells in response to Ca2+ and guanine nucleotides: an all-or-none event. J Cell Biol (1993) 0.97

Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis. J Mol Biol (2001) 0.97

Trifluoperazine, a calmodulin antagonist, inhibits muscle cell fusion. J Cell Biol (1983) 0.95

SCH 51344-induced reversal of RAS-transformation is accompanied by the specific inhibition of the RAS and RAC-dependent cell morphology pathway. Oncogene (1997) 0.94

Identification of a 130-kilodalton human biliary concanavalin A binding protein as aminopeptidase N. Gastroenterology (1994) 0.93

Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments. Diabetologia (2010) 0.93

Popliteal aneurysm after total knee arthroplasty. Case reports and review of the literature. J Arthroplasty (1990) 0.93

Mechanism-based inhibition of the melatonin rhythm enzyme: pharmacologic exploitation of active site functional plasticity. Proc Natl Acad Sci U S A (1999) 0.92

Delayed operative management of fractures of the scapula. J Bone Joint Surg Br (2009) 0.92

Induction of the cellular E2F-1 promoter by the adenovirus E4-6/7 protein. J Virol (2000) 0.91

Introduction of unlabeled proteins into living cells by electroporation and isolation of viable protein-loaded cells using dextran-fluorescein isothiocyanate as a marker for protein uptake. Anal Biochem (1991) 0.90

The strengths perspective of case management: a promising inpatient substance abuse treatment enhancement. J Psychoactive Drugs (1995) 0.90

Small bowel obstruction after colon resection for benign and malignant diseases. Dis Colon Rectum (1991) 0.90

Increased ischemia-reperfusion injury to the heart associated with short-term, diet-induced hypercholesterolemia in rabbits. Circ Res (1987) 0.88

CHMP6 and VPS4A mediate the recycling of Ras to the plasma membrane to promote growth factor signaling. Oncogene (2012) 0.87

Ly-49W, an activating receptor of nonobese diabetic mice with close homology to the inhibitory receptor Ly-49G, recognizes H-2D(k) and H-2D(d). J Immunol (2001) 0.87

Maisonneuve fracture equivalent with proximal tibiofibular dislocation. A case report and literature review. J Bone Joint Surg Am (2006) 0.87

Recovery and kinetic characteristics of desflurane and sevoflurane in volunteers after 8-h exposure, including kinetics of degradation products. Anesthesiology (1997) 0.87

Insulin-induced dissociation of Sos from Grb2 does not contribute to the down regulation of Ras activation. Oncogene (1996) 0.87

Crosslinking of the surface immunoglobulin receptor in B lymphocytes induces a redistribution of neurofibromin but not p120-GAP. Oncogene (1994) 0.87

Protein tyrosine kinase Csk-catalyzed phosphorylation of Src containing unnatural tyrosine analogues. J Am Chem Soc (2001) 0.86

Pediatric chance fractures from lapbelts: unique case report of three in one accident. J Orthop Trauma (1996) 0.86

Anoxia induces phospholipase A2 activation in rabbit renal proximal tubules. Am J Physiol (1992) 0.86

Indoleamine analogs as probes of the substrate selectivity and catalytic mechanism of serotonin N-acetyltransferase. J Biol Chem (1998) 0.85

Minimum alveolar anesthetic concentration of fluorinated alkanols in rats: relevance to theories of narcosis. Anesth Analg (1999) 0.85

Reliability of colonoscopy. Dis Colon Rectum (1989) 0.85

Maturation decreases ethanol minimum alveolar anesthetic concentration (MAC) more than desflurane MAC in rats. Anesth Analg (1997) 0.85

Bisubstrate ketone analogues as serotonin N-acetyltransferase inhibitors. J Med Chem (2001) 0.84

Maturation decreases ethanol minimum alveolar anesthetic concentration in mice as previously demonstrated in rats: there is no species difference. Anesth Analg (1997) 0.84